Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Trastuzumab duocarmazine in locally advanced and metastatic solid tumours and HER2-expressing breast cancer: a phase 1 dose-escalation and dose-expansion study
PaperCitations, authors & open-access status
Trastuzumab duocarmazine in locally advanced and metastatic solid tumours and HER2-expressing breast cancer: a phase 1 dose-escalation and dose-expansion study is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 575 citations, 2019 year and bronze oa status.
575
Citations
2019
Year
bronze
OA Status